Maven Securities LTD Merck & Co., Inc. Transaction History

Maven Securities LTD

$774 Million
Q3 2024

A detailed history of Maven Securities LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Maven Securities LTD holds 8,981 shares of MRK stock, worth $867,205. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,981

Previous 14,090 36.26%

Holding current value

$867,205

Previous $1.74 Million 41.57%

% of portfolio

0.13%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $567,865 - $658,907	-5,109 Reduced 36.26%	8,981 $1.02 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $1.41 Million - $1.51 Million	-11,381 Reduced 44.68%	14,090 $1.74 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $2.88 Million - $3.36 Million	25,471 New	25,471 $3.36 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $1.52 Million - $1.69 Million	14,812 Added 84.69%	32,302 $3.33 Million
Q2 2023 Aug 04, 2023	BUY	$108.61 - $118.38 $1.9 Million - $2.07 Million	17,490 New	17,490 $2.02 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $1.38 Million - $1.55 Million	16,342 Added 503.76%	19,586 $16.9 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $23,043 - $26,120	276 Added 9.3%	3,244 $296,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $218,177 - $244,563	2,968 New	2,968 $244,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $574,801 - $632,137	-8,019 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $563,815 - $623,637	8,019 New	8,019 $624,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $341,384 - $386,961	-4,665 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $328,509 - $373,806	4,665 New	4,665 $361,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Account

Maven Securities LTD Merck & Co., Inc. Transaction History